Cameron Health, Inc. announced that it has received CE mark approval for Subcutaneous Implantable Defibrillator (S-ICD) System. The system is prescribed for use in patients at risk of Sudden Cardiac Arrest. With out any leads in or on heart the system is implanted subcutaneously. No imaging equipment is required for placement of the S-ICD System.
The system and its components are positioned using anatomical landmarks.
Positioning just under the skin S-ICD System avoids many of the complications associated with the conventional implant procedure and long term performance. It is easily placed and removed there by shortening the surgical procedure time. It is the first totally subcutaneous implantable defibrillator used to treat SCA.
The President and CEO of Cameron Health, Inc. Jay Warren explains, “our goal was to develop a minimally invasive alternative to conventional ICD’s as well as tackle a number of the unmet needs of patients and physicians. We have made a number of significant advances, the foremost being that the Cameron Health S-ICD System obviates the need for transvenous lead placement.”
Commenting on the S-ICD System, Dr. Ian Crozier from ChristChurch in New Zealand said, “This new approach to ICD therapy is better for a significant portion of my ICD patients. The procedure is surgically simple and may reduce or eliminate some of the complexity inherent with transvenous electrodes. For the implanting clinician, not having to wear a protective lead apron to avoid radiation exposure during the procedure was refreshing.”
Darryl Ward, one of the first patients to receive the Cameron Health S-ICD System remarked, “I feel fortunate that this novel technology was available to me because my previous conventional ICD lead was no longer functioning. I just like the idea of nothing needing to be inside my heart anymore.”